|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
California Sues 39 Pharmaceutical Groups For Alleged Price Gouging
10/19/2005 5:09:10 PM
California has sued 39 US and foreign drug companies, charging that they inflated prices to the detriment of the state's health care system, the state's attorney general said. "We're dragging these drug companies into the court of law because they're gouging the public on basic life necessities," Bill Lockyer said in a statement. The suit was filed in a court in the northeastern city of Boston, Massachusetts, the statement said.
Lockyer accused the companies of having artificially inflated prices for products reimbursed by the state's health care program Medi-Cal, "resulting in a loss of potentially hundreds of millions of dollars."
California already sued two pharmaceutical companies for the same reason in 2003, but the suit was widened to a total of 39 companies when new evidence came to light, the statement said.
Companies named in the suit include US giants Abbott, GlaxoSmithKline and Merck, as well Boehringer of Germany, Glaxo Wellcome of Britain, Lipha of France, Pharma Investment of Canada and Teva of Israel.
|
|
|
|
|
|
|
|
|
|
|